Nowax ear drops

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ixtrih issa

Ingredjent attiv:

Cineole; Nutmeg oil; Arachis oil; Terpineol

Disponibbli minn:

Bell,Sons & Co (Druggists) Ltd

Kodiċi ATC:

n/a

INN (Isem Internazzjonali):

Cineole; Nutmeg oil; Arachis oil; Terpineol

Dożaġġ:

75microlitre/1ml ; 4microlitre/1ml ; 901microlitre/1ml ; 20microlitre/1ml

Għamla farmaċewtika:

Ear drops

Rotta amministrattiva:

Auricular

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Never Valid To Prescribe As A VMP

Sommarju tal-prodott:

BNF: ; GTIN: 5017848250820

Fuljett ta 'informazzjoni

                                65mm x 210mm
52.5mm each fold
65mm x 210mm
52.5mm each fold
                                
                                Aqra d-dokument sħiħ
                                
                            

Karatteristiċi tal-prodott

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Golden Ear Drops
Nowax Ear Drops
Superdrug Ear Wax Remover Drops
Wilko Ear Wax Removal Drops
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Eucalyptol
7.50
v/v BPC
Nutmeg Oil
0.40
v/v BP
Terpineol
2.00
v/v BP
Arachis Oil
90.10
v/v BP
For excipients see 6.1
3
PHARMACEUTICAL FORM
Ear drops, solution
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the loosening and removal of ear wax, and relief of any pain
associated
with the wax.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For aural use. Instil a few drops in the ear.
Warm the bottle to body temperature. With the head inclined to one
side instil
a few drops and insert a cotton wool plug.
Repeat at night and morning for a few days until wax is cleared.
If symptoms persist consult your doctor.
4.3
CONTRAINDICATIONS
Hypersensitivity to any of the active ingredients.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
For external use only.
Do not use if the ear is inflamed or infected.
If symptoms persist consult your doctor.
Keep out of the sight and reach of children.
This product contains arachis oil (peanut oil) and should not be
taken/applied by patients known to be allergic to peanut. As there is
a
possible relationship between allergy to peanut and allergy to soya,
patients
with soya allergy should also avoid this product.
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None
4.6
PREGNANCY AND LACTATION
Contains ingredients of adequate safety and therefore there are no
limitations
on its use during pregnancy and lactation.
4.7
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
None
4.8 UNDESIRABLE EFFECTS
None
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any
possible side effects not listed in this leaflet. You can also report
side effects directly
via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard by reporting
side
effects you can help provide more information on the safety of this
medicine.
4.9
OVERDOSE
N
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott

Ara l-istorja tad-dokumenti